Commercialization Generally. Endo shall use commercially reasonable efforts to Launch the Licensed Product promptly after Regulatory Approval of the Product ANDA and, at its own expense, to actively and diligently promote, market and sell the Licensed Product in the Territory during the term of this Agreement. Such efforts shall be no less than those efforts Endo would undertake for its own generic products with similar market potential.
Appears in 4 contracts
Samples: License Agreement (Endo Pharmaceuticals Holdings Inc), License Agreement (Noven Pharmaceuticals Inc), License Agreement (Noven Pharmaceuticals Inc)